Sanofi-Aventis's type i type i diabetes drug Lantus may rise the risk of cancer, as it should be to spanish studies involving some 300,000 insulin-treated patients, third editioncopyright © 2009 by the philip lief group.
cite this source



















main entry:
invitation
a call from experts for more research.

More: - Continued here